| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.378 | 1.722 | 783 | 903 | 644 | 492 | 573 | 552 | 731 | 605 |
| Gross Profit/Loss - EUR | -78 | -1.722 | -783 | -903 | -644 | -492 | -573 | -552 | -731 | -605 |
| Net Profit/Loss - EUR | -147 | -1.722 | -783 | -903 | -644 | -492 | -573 | -552 | -731 | -605 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medland S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 776 | 35 | 0 | 119 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.734 | 1.353 | 1.453 | 1.479 | 1.913 | 1.798 | 1.416 | 1.680 | 1.550 | 1.579 |
| Inventories | 512 | 507 | 674 | 662 | 705 | 691 | 676 | 678 | 676 | 672 |
| Receivables | 6.198 | 741 | 729 | 715 | 713 | 688 | 673 | 675 | 673 | 669 |
| Cash | 23 | 105 | 50 | 101 | 495 | 419 | 67 | 327 | 201 | 238 |
| Shareholders Funds | -5.622 | -7.287 | -7.946 | -8.703 | -9.178 | -9.497 | -9.859 | -10.442 | -11.141 | -11.684 |
| Social Capital | 157 | 156 | 153 | 150 | 148 | 145 | 142 | 142 | 142 | 141 |
| Debts | 13.132 | 8.675 | 9.399 | 10.301 | 11.092 | 11.295 | 11.275 | 12.121 | 12.691 | 13.263 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Medland S.r.l.